UNSPSC 51453106: Oxantel embonate

This classification denotes an antihelminthic agent with the molecular formula C23H16O6.C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UPY1D732T0, chemically known as 4,4-methylenebis(3-hydroxy-2-naphthoic) acid, compound with (e)-3-(2-(1,4,5,6-tetrahydro-1-methylpyrimidin-2-yl)vinyl)phenol (1:1) but more generally known as oxantel embonate, which bears US NIH Compound Identifier 5281086. Most nations, for tariff and trade purposes, schedule oxantel embonate under HS 29335995 and SITC 51576.

SMILES: CN1CCCN=C1/C=C/C2CCCC(C2)O.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51453106 Oxantel embonate (Commodity) comprises pharmaceutical products and related medical supplies procured by state and local health authorities, though recent state and local opportunities show limited direct activity under this specific code. The solicitations appearing in the record reflect a broader pattern of state and local procurement spanning emergency medical supplies, pharmacy benefit programs, and generic pharmaceutical distribution through authorized wholesalers and cooperative purchasing vehicles, rather than oxantel embonate procurement specifically. State and local issuing bodies pursuing pharmaceutical and medical supply contracts include county health departments, state health and human services commissions, municipal fire departments, and multistate cooperative purchasing alliances. The City of Tampa Fire Department, Seminole County, Florida, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the institutional mix, ranging from single-jurisdiction emergency response procurement to multi-state coordinated purchasing for generic drugs and OTC products.

The code shows recent activity across Florida, Texas, and Minnesota-led cooperative purchasing spanning multiple states including Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000 and designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount capped at $10,000; MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit managers and group purchasing organizations. The code itself shows sparse recent alignment with oxantel embonate procurement; the opportunities recorded reflect broader pharmaceutical and emergency medical supply categories rather than this specific anthelmintic product line.